Stock listing
NASDAQ:TCRX TScan Therapeutics, Inc. Stock
Home listing (NASDAQ) of TScan Therapeutics, Inc.
Follow TScan Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TCRX
$0.179 USD +0.005 (+2.7%)
Close on Nov 2, 2026
- Day range
- $0.175 – $0.190 USDNov 2, 2026
- Volume
- 497,329 sharesNov 2, 2026
- Market cap
- $11.38M USDAt the close on Nov 2, 2026 · price × 63.50M shares outstanding
- 52-week range
- $0.173 – $1.480 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $282,070 USDMedian day 542,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TCRX · Home | $0.179 USD | +0.005 (+2.7%) | 497,329 | $0.181 | $0.190 | $0.175 | $0.175 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TCRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.179 | +0.005 | +2.7% | $0.181 | $0.190 | $0.175 | 497,329 | |
| $0.175 | -0.020 | -10.5% | $0.193 | $0.193 | $0.173 | 333,158 | |
| $0.195 | -0.004 | -2.0% | $0.194 | $0.197 | $0.185 | 57,870 | |
| $0.199 | +0.007 | +3.6% | $0.187 | $0.200 | $0.183 | 358,909 | |
| $0.192 | +0.002 | +1.2% | $0.190 | $0.197 | $0.183 | 539,679 | |
| $0.190 | -0.013 | -6.6% | $0.204 | $0.204 | $0.180 | 801,084 | |
| $0.203 | -0.013 | -6.0% | $0.221 | $0.227 | $0.202 | 262,800 | |
| $0.216 | -0.008 | -3.6% | $0.215 | $0.224 | $0.215 | 299,100 | |
| $0.224 | 0.000 | 0.0% | $0.220 | $0.224 | $0.212 | 688,200 | |
| $0.224 | +0.014 | +6.7% | $0.214 | $0.234 | $0.211 | 559,600 | |
| $0.210 | -0.021 | -9.1% | $0.238 | $0.238 | $0.210 | 368,300 | |
| $0.231 | -0.008 | -3.3% | $0.238 | $0.245 | $0.230 | 568,200 | |
| $0.239 | +0.028 | +13.3% | $0.216 | $0.243 | $0.209 | 878,800 | |
| $0.211 | -0.006 | -2.8% | $0.224 | $0.228 | $0.201 | 546,600 | |
| $0.217 | -0.021 | -8.8% | $0.240 | $0.240 | $0.212 | 461,400 | |
| $0.238 | 0.000 | 0.0% | $0.240 | $0.249 | $0.230 | 483,500 | |
| $0.238 | +0.010 | +4.4% | $0.228 | $0.247 | $0.228 | 869,300 | |
| $0.228 | -0.049 | -17.7% | $0.271 | $0.273 | $0.224 | 1,534,600 | |
| $0.277 | +0.002 | +0.7% | $0.271 | $0.283 | $0.263 | 542,100 | |
| $0.275 | -0.020 | -6.8% | $0.293 | $0.296 | $0.264 | 601,900 | |
| $0.295 | -0.026 | -8.1% | $0.317 | $0.330 | $0.285 | 749,900 | |
| $0.321 | +0.003 | +0.9% | $0.330 | $0.330 | $0.316 | 144,400 | |
| $0.318 | +0.003 | +1.0% | $0.319 | $0.329 | $0.311 | 622,700 | |
| $0.315 | -0.003 | -0.9% | $0.322 | $0.345 | $0.315 | 554,400 | |
| $0.318 | -0.022 | -6.5% | $0.339 | $0.346 | $0.311 | 753,200 | |
| $0.340 | 0.000 | 0.0% | $0.340 | $0.348 | $0.325 | 359,200 | |
| $0.340 | -0.009 | -2.6% | $0.352 | $0.370 | $0.330 | 381,900 | |
| $0.349 | -0.015 | -4.1% | $0.369 | $0.369 | $0.340 | 606,700 | |
| $0.364 | +0.009 | +2.5% | $0.360 | $0.372 | $0.341 | 1,081,000 | |
| $0.355 | +0.024 | +7.3% | $0.333 | $0.360 | $0.330 | 918,500 | |
| $0.331 | +0.019 | +6.1% | $0.311 | $0.342 | $0.311 | 752,900 | |
| $0.312 | -0.022 | -6.6% | $0.343 | $0.357 | $0.310 | 1,143,200 | |
| $0.334 | +0.003 | +0.9% | $0.335 | $0.362 | $0.324 | 1,096,300 | |
| $0.331 | +0.010 | +3.1% | $0.330 | $0.340 | $0.321 | 883,900 | |
| $0.321 | +0.015 | +4.9% | $0.316 | $0.322 | $0.290 | 677,200 | |
| $0.306 | -0.014 | -4.4% | $0.320 | $0.334 | $0.306 | 1,104,000 | |
| $0.320 | +0.002 | +0.6% | $0.324 | $0.325 | $0.306 | 873,100 | |
| $0.318 | -0.012 | -3.6% | $0.320 | $0.350 | $0.310 | 804,600 | |
| $0.330 | -0.015 | -4.3% | $0.340 | $0.343 | $0.330 | 704,200 | |
| $0.345 | -0.047 | -12.0% | $0.380 | $0.380 | $0.330 | 1,536,300 | |
| $0.392 | +0.021 | +5.7% | $0.370 | $0.417 | $0.365 | 1,674,000 | |
| $0.371 | -0.010 | -2.6% | $0.381 | $0.402 | $0.351 | 3,091,000 | |
| $0.381 | -0.285 | -42.8% | $0.550 | $0.570 | $0.360 | 8,517,400 | |
| $0.666 | -0.064 | -8.8% | $0.723 | $0.770 | $0.656 | 820,300 | |
| $0.730 | -0.024 | -3.2% | $0.750 | $0.766 | $0.721 | 330,100 | |
| $0.754 | +0.004 | +0.5% | $0.755 | $0.780 | $0.750 | 150,700 | |
| $0.750 | -0.027 | -3.5% | $0.777 | $0.800 | $0.747 | 287,800 | |
| $0.777 | -0.017 | -2.1% | $0.778 | $0.792 | $0.774 | 68,300 | |
| $0.794 | -0.005 | -0.6% | $0.792 | $0.811 | $0.777 | 180,600 | |
| $0.799 | +0.019 | +2.4% | $0.790 | $0.800 | $0.768 | 194,400 | |
| $0.780 | +0.004 | +0.5% | $0.790 | $0.790 | $0.772 | 136,200 | |
| $0.776 | +0.026 | +3.5% | $0.750 | $0.789 | $0.750 | 338,300 | |
| $0.750 | -0.075 | -9.1% | $0.770 | $0.825 | $0.750 | 580,100 | |
| $0.825 | +0.041 | +5.2% | $0.770 | $0.838 | $0.770 | 173,500 | |
| $0.784 | +0.005 | +0.6% | $0.780 | $0.795 | $0.763 | 352,800 | |
| $0.779 | +0.007 | +0.9% | $0.768 | $0.789 | $0.741 | 278,400 | |
| $0.772 | -0.001 | -0.1% | $0.779 | $0.790 | $0.764 | 297,600 | |
| $0.773 | -0.004 | -0.5% | $0.791 | $0.791 | $0.751 | 528,000 | |
| $0.777 | +0.010 | +1.3% | $0.772 | $0.799 | $0.764 | 248,100 | |
| $0.767 | -0.029 | -3.6% | $0.800 | $0.800 | $0.762 | 464,300 | |
| $0.796 | +0.033 | +4.3% | $0.754 | $0.804 | $0.754 | 336,300 | |
| $0.763 | -0.017 | -2.2% | $0.771 | $0.781 | $0.750 | 129,800 | |
| $0.780 | +0.043 | +5.8% | $0.745 | $0.780 | $0.745 | 298,600 | |
| $0.737 | +0.014 | +1.9% | $0.716 | $0.758 | $0.716 | 796,200 | |
| $0.723 | -0.020 | -2.7% | $0.759 | $0.780 | $0.720 | 441,400 |
- Ticker
- NASDAQ:TCRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 2, 2026
TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors
Latest deck · Sep 2, 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors
Sep 2, 2026
Closed $0.381 (-42.8%) on Sep 2, 2026
TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 12, 2026
Closed $0.773 (-0.5%) on Aug 12, 2026
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies
Jul 30, 2026
Closed $0.756 (+1.9%) on Jul 30, 2026
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun 24, 2026
Closed $0.881 (-4.3%) on Jun 24, 2026
TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation
Jun 22, 2026
Closed $0.865 (-6.0%) on Jun 22, 2026
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
Jun 3, 2026
Closed $0.972 (-0.8%) on Jun 3, 2026
TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026
Closed $1.25 (+3.3%) on May 6, 2026
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
Apr 27, 2026
Closed $1.26 (-3.8%) on Apr 28, 2026
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
Apr 8, 2026
Closed $1.06 (-0.9%) on Apr 8, 2026
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 4, 2026
Closed $1.08 (+4.3%) on Mar 4, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · Sep 2, 2026
Investor Presentation (September 2026)
Investor deck · 22 slides · September 2026
Technical Presentation (June 2026)
Technical · 65 slides · Jun 22, 2026
Corporate Update (June 2026)
Corporate update · 48 slides · June 2026
TScan Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 99 in all · newest Sep 2, 2026 · oldest 2021
- Decks
- 13 decks · latest Sep 2, 2026
Where TScan Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TCRX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TCRX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about TScan Therapeutics, Inc.